Response to "the corporate coauthor".
作者信息
Wager Elizabeth, Jacobs Adam
出版信息
J Gen Intern Med. 2005 Jul;20(7):672. doi: 10.1111/j.1525-1497.2005.051181.x.
Abstract
摘要
相似文献
1
Response to "the corporate coauthor".对“共同作者公司”的回应。
J Gen Intern Med. 2005 Jul;20(7):672. doi: 10.1111/j.1525-1497.2005.051181.x.
2
The corporate coauthor.企业合著者。
J Gen Intern Med. 2005 Jun;20(6):546-8. doi: 10.1111/j.1525-1497.2005.05857.x.
3
[Knowledge on feet of clay].[徒有其表的知识]
Lakartidningen. 2008;105(19):1405-6.
4
[Ghostwriting].（代笔）
Tidsskr Nor Laegeforen. 2008 May 1;128(9):1039.
5
[The journals must honestly tell who is doing the job].这些期刊必须诚实地说明是谁在做这项工作。
Lakartidningen. 2008;105(19):1406-7.
6
Scientific discourse, corporate ghostwriting, journal policy, and public trust.科学论述、代笔捉刀、期刊政策与公众信任
J Gen Intern Med. 2005 Jun;20(6):550-1. doi: 10.1111/j.1525-1497.2005.41008.x.
7
The sins of ghostwriting.代笔的罪过。
Am J Ther. 2008 Jul-Aug;15(4):297-8. doi: 10.1097/MJT.0b013e318180f387.
8
Sponsorship, authorship and accountability.赞助、作者身份与责任。
CMAJ. 2001 Sep 18;165(6):786-8.
9
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况
Mayo Clin Proc. 2010 Feb;85(2):196-7; author 201-4. doi: 10.4065/mcp.2009.0616.
10
Comments on "The corporate author".关于“集体作者”的评论
J Gen Intern Med. 2005 Oct;20(10):972; author reply 972-3. doi: 10.1111/j.1525-1497.2005.051391_1.x.
引用本文的文献
1
A literature review of non-financial conflicts of interest in healthcare research and publication.医疗保健研究与出版中利益冲突的文献综述。 （原文表述似乎有误，推测正确内容为“A literature review of non - financial conflicts of interest in healthcare research and publication”，翻译为“医疗保健研究与出版中非财务利益冲突的文献综述” ）
按照正确内容翻译为：医疗保健研究与出版中非财务利益冲突的文献综述。
BMC Med Ethics. 2025 May 15;26(1):61. doi: 10.1186/s12910-025-01221-5.
本文引用的文献
1
The corporate coauthor.企业合著者。
J Gen Intern Med. 2005 Jun;20(6):546-8. doi: 10.1111/j.1525-1497.2005.05857.x.
2
European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.欧洲医学撰写人协会（EMWA）关于医学撰写人在同行评审出版物撰写中所起作用的指南。
Curr Med Res Opin. 2005 Feb;21(2):317-22. doi: 10.1185/030079905X25578.
3
Good publication practice for pharmaceutical companies.制药公司良好出版规范。
Curr Med Res Opin. 2003;19(3):149-54. doi: 10.1185/030079903125001767.
4
When authorship fails. A proposal to make contributors accountable.当署名制失灵时。让贡献者承担责任的一项提议。
JAMA. 1997 Aug 20;278(7):579-85. doi: 10.1001/jama.278.7.579.
Zotero 插件